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Sudden infant death syndrome (SIDS) is deﬁned as the
sudden and unexpected death of an apparently healthy infant
younger than 1 year of age.1 The occurrence of SIDS is
described by a triple risk model involving a critical
developmental period in combination with environmental
and genetic risk factors; however, the pathophysiological
mechanisms responsible for SIDS still remain poorly
understood.2 Technical advances in high-throughput massive
parallel sequencing recently enabled broad genetic analyses
in large SIDS cohorts and identiﬁed likely pathogenic
sequence alterations in cardiovascular disease–associated
genes in up to 30% of SIDS victims.3,4 Approximately
10%–15% of these sudden death cases are believed to be
caused by cardiac channelopathies, which can cause lethal
arrhythmias in absence of any structural changes in the
heart.3–5
Voltage-gated sodium channels are integral membrane
proteins primarily found in cardiac muscle cells, where they
are involved in the generation and propagation of action
potentials.6 The Na1 current (INa) is determined not only by
the pore-forming a subunit (Nav1.5), but also by regulatory
b subunits (b1-b4). The voltage-gated sodium channel b1B
subunit gene (SCN1B) is expressed into 2 isoforms, the trans-
membrane b1 subunit and the soluble b1B subunit, which in-
cludes a retained intron encoding a novel C-terminus, stop
codon, and polyadenylation site.7 Mutations in SCN1B have
been reported inmultiple inherited cardiac diseases, including
congenital long QT syndrome, Brugada syndrome, cardiacKEYWORDS Cardiac channelopathy; Electrophysiological analysis; SCN1B;
Sudden infant death syndrome; Whole-cell patch clamp; Whole-exome
sequencing
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and SIDS.8 In addition, SCN1B loss-of-function mutations
have been described in Dravet syndrome, a devastating pedi-
atric epileptic encephalopathy with a high mortality during
early childhood, mainly owing to sudden, unexpected death
in epilepsy.9
Here, we report the electrophysiological effect of a rare
SCN1B b1B subunit variant identiﬁed in the whole-exome
sequencing data of a 5-month-old male SIDS case.Case report
The 5-month old male infant (weight 6540 g; height 64 cm;
European origin) was found dead in his cot early in the
morning in a safe sleeping environment with no evidence
of an accidental death. He was born full-term following a
normal and uncomplicated pregnancy and was the
third-born son of a 34-year-old healthy woman. The boy
was vaccinated against diphtheria, tetanus, pertussis, and
poliomyelitis, with a last vaccination 13 days prior to his
death. During his months of life, no anomalous clinical
events were reported except for a large head, with a head
circumference greater than the 97th percentile. According
to his parents, the boy slept a great deal and they often had
difﬁculties awakening him.
A comprehensive autopsy investigation revealed normal
sizes and structures of all organs and no signs of malforma-
tion, malignancy, or infections. In addition, microbiological
and toxicological screening tests were all negative. As the
cause of death remained unexplained, the case was assigned
to SIDS category I based on the San Diego deﬁnition.1
Ethical approval for this study was provided by the local
ethics committee (KEK-ZH-Nr. 2013-0086), and the study
was conducted in full conformance with Swiss laws and
regulations. Family members were not available for
co-segregation analyses owing to the speciﬁcations in the
ethical approval for this study.
Whole-exome sequencing and variant analysis has been
performed within a large genetic screening study in 161en access article
.0/).
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KEY TEACHING POINTS
 Sudden infant death syndrome (SIDS) is deﬁned as
the sudden death of a healthy infant younger than 1
year of age without any obvious cause of death.
Despite intensive genetic investigations, the
underlying pathophysiological mechanism still
remains elusive in most of the cases.
 Whole-exome sequencing in a 5-month-old male
infant identiﬁed a heterozygous missense variant in
the b1B subunit of SCN1B. Electrophysiological
recordings of Nav1.5 co-expressed with the b1B
subunit variant p.R225C induced a loss of function
of Nav1.5 channels.
 The loss of function might have contributed to the
sudden death event in this infant; however, further
investigations are needed. This study demonstrates
the importance of careful evaluation of likely
pathogenic variants identiﬁed within next-
generation sequencing approaches for an accurate
interpretation of genetic results.
Figure 1 Sanger sequencing conﬁrmation of SCN1B c.673C.T,
p.R225C.
188 Heart Rhythm Case Reports, Vol 4, No 5, May 2018SIDS infants.4 The 5-month-old boy carried a heterozygous
missense variant (NM_199037.4, rs369588692, c.673C.T,
p.R225C) in SCN1B (Figure 1). The sequence variation is
located in exon 3A, which is unique to the alternative splice
isoform b1B. The variant p.R225C was found to be very rare
in the European (non-Finnish) population (minor allele
frequency: 0.01%) in the NHLBI GO Exome Sequencing
Project. The in silico protein prediction of the SCN1B variant
was based on 6 different tools according to the recommenda-
tions of the American College of Medical Genetics standards
and guidelines for the interpretation of sequence variants.10
Four in silico protein prediction tools categorized the variant
as disease-causing (MutationTaster, SIFT, MAPP, and Gran-
tham distance score), whereas 2 in silico protein prediction
tools categorized the variant as benign (AGVGD and
PolyPhen-2). In summary, the SCN1B sequence alteration
was classiﬁed as a variant of uncertain signiﬁcance owing
to the absence of co-segregation and functional analyses.10
The electrophysiological effects of the 2 WT b-isoforms
(b1 and b1B) and the b1B subunit variant on Nav1.5 sodium
current were assessed via the whole-cell patch clamp
technique using transiently transfected HEK293 cells.
Parameters for Na1 current density and voltage dependence
of activation and inactivation are listed in Table 1.
Figure 2A shows representative current traces in cells
expressing Nav1.5 alone and Nav1.5 plus b1 WT, b1B WT,
or mutant b1B. Co-expression of Nav1.5 with b1B subunit
WT or b1B p.R225C showed a signiﬁcant increase of the
sodium current density compared to Nav1.5 plus b1 WT
and Nav1.5 alone (Figure 2B, Table 1). The steady-state acti-
vation was similar for all conditions (Figure 2C); however,co-expression ofNav1.5withb1BWT induced a depolarizing
shift of the steady-state inactivation curves, leading overall to
a gain-of-function (Figure 2D). Interestingly, compared to
b1B WT, co-expression of Nav1.5 with b1B-subunit
p.R225C variant leads to a hyperpolarization of the steady-
state inactivation relationship (Figure 2D). Consequently,
compared to b1B subunit WT, b1B subunit p.R225C reduces
the number of available channels for a given voltage, which
leads to a loss of function of Nav1.5 channels.Discussion
Here, we describe the results of whole-cell patch clamp anal-
ysis of a rare heterozygous missense variant in the b1B sub-
unit of SCN1B found in a male SIDS infant. Sequence
alterations in different b subunits (SCN1B–SCN4B) have
been associated with different cardiac diseases.11 Altered
Nav1.5 sodium channel function owing to b-subunit
mutations may account for the molecular pathogenic mecha-
nism in approximately 1% of SIDS cases.
In this study, the co-expression of theWT b1B subunit led
to increased sodium current when compared to the WT b1
subunit or Nav1.5 alone. The effects of b1B subunit on
Nav1.5 channels are controversial, as some groups have
reported functional differences between the 2 isoforms,
with or without affecting voltage dependences or channel
kinetics, while others reported no effects.8 In addition, it is
Table 1 Parameters for Na1-current density, activation, and inactivation
Current density (pA/pF) Steady-state activation (SSA) Steady-state inactivation (SSI)
n n V1/2 (mV) k n V1/2 (mV) k
Nav1.5 alone 10 257.94 6 19.34 13 222.70 6 0.77 5.43 6 0.17 12 268.06 6 0.65 4.90 6 0.19
Nav1.5 1 b1 WT 19 267.11 6 10.04 12 223.90 6 1.37 5.64 6 0.19 14 268.94 6 0.59 4.78 6 0.11
Nav1.5 1 b1B WT 17 2106.21 6 11.71* 10 223.83 6 1.29 5.08 6 0.17 13 265.50 6 0.54* 4.59 6 0.14
Nav1.5 1 b1B R225C 23 2111.41 6 9.04* 5 224.19 6 0.69 5.32 6 0.13 20 268.52 6 0.52 4.77 6 0.15
k 5 slope; n 5 number of recordings; V1/2 5 voltage of half-maximal activation/inactivation.
*P , .05 vs Nav1.5 alone, compared by paired 2-tailed Student t test.
Neubauer et al Functional Characterization of an SCN1B Variant 189important to note that the b1B isoform is not a transmem-
brane protein, but a soluble peptide whose function is still
poorly understood.7 The 2 b1 isoforms are expressed not
only in the human heart, but also in the brain, with the highest
amount of the b1B subunit during embryonic development
where the soluble b1B protein functions as a ligand for
b-mediated neurite migration and outgrowth.9 Genetic
variants in the b1B gene were furthermore described as a
risk factor for human epilepsy,7 which might be another
possible terminal pathway in SIDS infants.
The p.R225C variant is located in the retained region of
b1B, which is unique to this isoform. Since close located
variants have been described in congenital long QT
syndrome, Brugada syndrome, lone atrial ﬁbrillation, DravetFigure 2 Electrophysiological characteristics of SCN1B. A: Representative trace
b1B subunit p.R225C in HEK293 cells. B: Sodium current density for Nav1.5 alon
dependence of steady-state activation for Nav1.5 alone, b1 subunit WT, b1B subu
inactivation for Nav1.5 alone, b1 subunit WT, b1B subunit WT, and b1B subuni
the mean. *P , .05 and **P , .01, based on a paired 2-tailed Student t test.syndrome, and idiopathic epilepsy,8,9,11 the identiﬁed variant
in the present study represents an interesting candidate
sequence alteration in the pathophysiological mechanisms
contributing to the sudden death event. Therefore, the loss
of function of the p.R225C variant might have contributed
to the occurrence of a lethal arrhythmia or epileptic seizure
in combination with other genetic or environmental risk
factors. However, owing to the controversial literature
reports and our own ﬁndings, further investigations are
needed to clarify the role and function of the 2 b1 isoforms
and the variant.
During recent years, next-generation sequencing
approaches facilitated the genetic investigations of patients
with complex genetic patterns or the identiﬁcation ofs of sodium current with Nav1.5 alone, b1 subunit WT, b1B subunit WT, and
e, b1 subunit WT, b1B subunit WT, and b1B subunit p.R225C. C: Voltage
nit WT, and b1B subunit p.R225C. D: Voltage dependence of steady-state
t p.R225C. In B, C, and D data points represent mean 6 standard error of
190 Heart Rhythm Case Reports, Vol 4, No 5, May 2018underlying genetic causes in large study populations in a
time- and cost-efﬁcient manner. However, the generation of
such huge amounts of data requires very stringent variant
evaluation systems in order to separate false-positive variants
from truly disease-causing sequence alterations.10,12 Several
studies have demonstrated that many variants previously
associated with cardiac diseases have in fact no or only
minor functional effects and are therefore less likely
associated with a dominant form of the disease; still, they
could act as a risk modiﬁer.13 Therefore, functional studies
are required and recommended for an evidence-based classi-
ﬁcation and interpretation of the pathogenicity of variants
identiﬁed in genetic SIDS studies so far.10,14
One limitation of this study is the lack of family members
for genetic testing and co-segregation analysis. This would
be necessary to determine the mode of inheritance, to classify
variants into the pathogenic category,15 and to identify other
genetic carriers at risk for sudden cardiac death. Additional
limitations are related to the functional assay. Electrophysio-
logical recordings were conducted in a conventional
heterologous expression system where the environment is
different from adult rod-shaped cardiomyocytes. Therefore,
the effects of many proteins known to associate with the
sodium channel complex could not be investigated. In
addition, only little is known about the function and
physiological role of the b1B isoform, emphasizing the
need to further investigate the function and expression of
this isoform in native tissues.
Conclusion
Electrophysiological investigations of the b1B p.R225C
variant showed signiﬁcant differences compared to the WT
variant, suggesting a loss of function of sodium current.
The potential effect on the cardiac or brain function of this
variant needs to be further clariﬁed in multiple populations
and co-segregation studies. This study highlights the impor-
tance of a careful evaluation of likely pathogenic variants
identiﬁed within next-generation sequencing data. Even if
variants are categorized as disease-causing according to in
silico protein predictions tools, the performance of additional
functional analyses is essential for an accurate interpretation
of genetic results.Acknowledgments
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